Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
published in: The Lancet
date of publication: 2013-01-08
language: English
main subject: anti-retroviral agent, dolutegravir, raltegravir
Cites articles 20
- 2012-06-01
Date
Title
Article - wd:Q44304694